PMD Device Solutions AB (OSTO:PMDS) ROCE % : 0.00% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is PMD Device Solutions AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PMD Device Solutions AB's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.00%.

PMD Device Solutions AB ROCE % Historical Data

The historical data trend for PMD Device Solutions AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PMD Device Solutions AB ROCE % Chart

PMD Device Solutions AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-65.74

-76.46

-81.64

-94.57

PMD Device Solutions AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-650.76	-	-	-	-

PMD Device Solutions AB ROCE % Calculation

PMD Device Solutions AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	0	/	( ( (21.006 - 6.304)	+	(39.479 - 96.774) )	/ 2 )
	=	0	/	( (14.702	+	-57.295)	/ 2 )
	=	0	/	-21.2965
	=	0.00 %

PMD Device Solutions AB's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-40.472	/	( ( (114.196 - 209.035)	+	(118.972 - 211.514) )	/ 2 )
	=	-40.472	/	( ( -94.839	+	-92.542 )	/ 2 )
	=	-40.472	/	-93.6905
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

PMD Device Solutions AB (OSTO:PMDS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PMD Device Solutions AB ROCE % Related Terms

Thank you for viewing the detailed overview of PMD Device Solutions AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PMD Device Solutions AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PMD Device Solutions AB (OSTO:PMDS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Eversheds Sutherland Advokatbyra AB, Box 14055, Stockholm, SWE, 104 40

Website

https://www.pmd-solutions.com

PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.

PMD Device Solutions AB Headlines

No Headlines